Trump revokes Biden order promoting competition in the US economy

President Donald Trump has revoked Joe Biden's 2021 executive order on promoting competition, effectively unwinding a key initiative designed to curb corporate abuses, excessive fees, and market concentration across diverse sectors. The Trump administration's Justice Department welcomed the move, advocating for an 'America first antitrust' approach focused on free markets and streamlining merger reviews, contrasting it with Biden's 'overly prescriptive' strategy. This reversal signals a significant policy shift towards deregulation, potentially fostering increased industry consolidation and altering the landscape for corporate market power and consumer protection.

Analysis

The revocation of the 2021 executive order on competition marks a significant pivot in U.S. antitrust policy, shifting from the Biden administration's aggressive enforcement against corporate concentration to a more laissez-faire, 'America first antitrust' approach. This new framework, as articulated by the Justice Department, prioritizes free markets and aims to streamline the Hart-Scott-Rodino (HSR) merger review process, suggesting a more permissive environment for M&A activity. The prior order specifically targeted what it termed 'corporate abuses' across sectors like agriculture, pharmaceuticals, labor, and healthcare, with a focus on issues such as excessive airline fees and the effects of monopoly power on consumers. The reversal signals reduced regulatory headwinds for dominant firms in these industries. However, the policy change is not without documented risk; a cited analysis linked similar deregulatory moves against the Consumer Financial Protection Bureau to an estimated $18 billion in costs to American consumers, indicating that while corporate consolidation may be facilitated, it could come at the expense of consumer welfare.

Key Decisions for Investors

• Investors should anticipate an increase in M&A activity and may consider positioning in potential acquisition targets, as the streamlined HSR review process and a more lenient antitrust stance lower regulatory hurdles for corporate consolidation.
• Re-evaluate positions in sectors previously targeted by the 2021 order, such as healthcare, airlines, and technology, as dominant players may benefit from reduced regulatory scrutiny, potentially leading to margin expansion.
• Monitor consumer-facing sectors for potential headwinds, as policies favoring corporate power over consumer protection could lead to higher prices and fees, potentially dampening consumer spending over the long term.
• Given the stated popularity of the original order, investors should remain aware of the political risk that this deregulatory environment could be reversed by a future administration, creating policy uncertainty for long-horizon investments in highly concentrated industries.